1. Home
  2. IBTX vs KYMR Comparison

IBTX vs KYMR Comparison

Compare IBTX & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBTX
  • KYMR
  • Stock Information
  • Founded
  • IBTX 2002
  • KYMR 2015
  • Country
  • IBTX United States
  • KYMR United States
  • Employees
  • IBTX N/A
  • KYMR N/A
  • Industry
  • IBTX Major Banks
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • IBTX Finance
  • KYMR Health Care
  • Exchange
  • IBTX Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • IBTX 2.8B
  • KYMR 3.0B
  • IPO Year
  • IBTX 2013
  • KYMR 2020
  • Fundamental
  • Price
  • IBTX $63.57
  • KYMR $41.96
  • Analyst Decision
  • IBTX Buy
  • KYMR Buy
  • Analyst Count
  • IBTX 7
  • KYMR 13
  • Target Price
  • IBTX $59.71
  • KYMR $51.15
  • AVG Volume (30 Days)
  • IBTX 240.2K
  • KYMR 415.6K
  • Earning Date
  • IBTX 10-21-2024
  • KYMR 10-31-2024
  • Dividend Yield
  • IBTX 2.39%
  • KYMR N/A
  • EPS Growth
  • IBTX N/A
  • KYMR N/A
  • EPS
  • IBTX N/A
  • KYMR N/A
  • Revenue
  • IBTX $466,720,000.00
  • KYMR $87,563,000.00
  • Revenue This Year
  • IBTX N/A
  • KYMR N/A
  • Revenue Next Year
  • IBTX $19.53
  • KYMR $21.47
  • P/E Ratio
  • IBTX N/A
  • KYMR N/A
  • Revenue Growth
  • IBTX N/A
  • KYMR 86.92
  • 52 Week Low
  • IBTX $36.16
  • KYMR $17.89
  • 52 Week High
  • IBTX $67.92
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • IBTX 57.20
  • KYMR 34.56
  • Support Level
  • IBTX $56.75
  • KYMR $45.16
  • Resistance Level
  • IBTX $67.92
  • KYMR $53.23
  • Average True Range (ATR)
  • IBTX 1.77
  • KYMR 2.58
  • MACD
  • IBTX 0.30
  • KYMR -0.54
  • Stochastic Oscillator
  • IBTX 61.06
  • KYMR 1.66

About IBTX Independent Bank Group Inc

Independent Bank Group Inc is a bank holding company. It offers services such as checking and savings accounts, debit cards, online banking, including online account opening, mobile banking, eStatements and bank-by-mail and direct deposit services. The Company also offers business accounts and management services, including analyzed business checking, business savings, and treasury management services. The Company derives its income principally from interest earned on loans and, to a lesser extent, income from securities available for sale and securities held to maturity. The Company also derives income from noninterest sources, such as fees received in connection with various deposit services, mortgage banking operations and investment advisory services.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Share on Social Networks: